Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
|
|
Quince Therapeutics, Inc. (CRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2023 |
4
| Thye Dirk (CEO) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Bought 88,000 shares
@ $1.26, valued at
$110.9k
|
|
| 08/09/2023 |
4
| Thye Dirk (CEO) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Bought 80,000 shares
@ $1.24, valued at
$99.2k
|
|
| 08/09/2023 |
4
| Hannah Brendan (Chief Business Officer) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Bought 71,762 shares
@ $1.22, valued at
$87.5k
|
|
| 08/09/2023 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Bought 8,000 shares
@ $1.23, valued at
$9.8k
|
|
| 05/26/2023 |
4
| Senner Christopher J. (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 05/26/2023 |
4
| RYAN UNA S (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 05/26/2023 |
4
| McLoughlin Margaret (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 05/26/2023 |
4
| Lamond David (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 05/26/2023 |
4
| Bray June (Director) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Granted 27,000 options to buy
@ $1.58, valued at
$42.7k
|
|
| 03/06/2023 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Sold 1,871 shares
@ $0.98, valued at
$1.8k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,640 shares
@ $0.72, valued at
$1.2k
|
|
| 09/08/2022 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Quince Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,520 shares
@ $1.64, valued at
$2.5k
|
|
| 07/01/2022 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 250,000 options to buy
@ $2.26, valued at
$565k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 27,000 options to buy
@ $3.23, valued at
$87.2k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Paid exercise price by delivering 1,529 shares
@ $3.12, valued at
$4.8k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| McDowell Caryn Gordon (Chief Legal & Adm. Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Paid exercise price by delivering 6,700 shares
@ $2.8632, valued at
$19.2k
Sold 10,800 shares
@ $2.8632, valued at
$30.9k
|
|
| 05/23/2022 |
4
| Thye Dirk (CEO) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 64,589 shares
@ $0
Granted 206,391 options to buy
@ $0.55, valued at
$113.5k
Granted 1,979,650 options to buy
@ $2.98, valued at
$5.9M
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Lamond David (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 200,002 shares
@ $0 |
|
| 05/23/2022 |
4
| Hannah Brendan (Chief Business Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 16,224 shares
@ $0
Granted 103,500 options to buy
@ $0.55, valued at
$56.9k
Granted 353,656 options to buy
@ $2.98, valued at
$1.1M
|
|
| 03/16/2022 |
4
| Sabbagh Marwan (Director) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 22,058 options to buy
@ $4.79, valued at
$105.7k
|
|
| 03/04/2022 |
4
| Monohon Ted (Chief Accounting Officer & VP) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 34,000 shares
@ $0 |
|
| 03/04/2022 |
4
| McDowell Caryn Gordon (Chief Legal & Adm. Officer) has filed a Form 4 on Cortexyme, Inc.|
Txns:
| Granted 140,000 shares
@ $0 |
|
|
|
|